**Core Concept**
The patient's presentation is indicative of a major depressive disorder, characterized by persistent sadness, loss of interest in activities, changes in appetite and sleep patterns, and suicidal ideation. This condition is often associated with disturbances in neurotransmitter systems, particularly serotonin and dopamine.

**Why the Correct Answer is Right**
The treatment of choice for major depressive disorder involves medications that target these neurotransmitter systems. Selective serotonin reuptake inhibitors (SSRIs) are a preferred class of antidepressants, as they increase the availability of serotonin in the synaptic cleft by inhibiting its reuptake. This leads to an increase in serotonin levels, which can help alleviate depressive symptoms. Other treatment options may include mood stabilizers, atypical antipsychotics, or electroconvulsive therapy (ECT) in severe cases.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while benzodiazepines may provide temporary relief from anxiety symptoms, they do not address the underlying pathophysiology of major depressive disorder and can even exacerbate the condition when used as a long-term solution.
**Option B:** This option is incorrect because antipsychotics are typically used to treat psychotic symptoms, such as hallucinations or delusions, which are not present in this patient's history.
**Option C:** This option is incorrect because while mood stabilizers may be used in the treatment of bipolar disorder, they are not the primary treatment for major depressive disorder.

**Clinical Pearl / High-Yield Fact**
It's essential to note that antidepressant medications can take several weeks to show efficacy, and patients should be monitored closely for signs of improvement or worsening symptoms.

**Correct Answer: A. Fluoxetine (an SSRI)**